Last €110.71 EUR
Change Today +1.55 / 1.42%
Volume 2.2M
BAYN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 3:45 PM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Werner Baumann

Chief Financial Officer and Member of Management Board, Bayer AG
AgeTotal Calculated CompensationThis person is connected to 47 board members in 2 different organizations across 6 different industries.

See Board Relationships
52€3,134,000
As of Fiscal Year 2013

Background*

Mr. Werner Baumann has been the Chief Financial Officer of Bayer AG since May 2010 and its Member of Management Board since January 1, 2010. Mr. Baumann served as the President of Business Development & Licensing of Bayer HealthCare AG since March 1, 2006 and also its President of Central Administration & Organization since July 2002. He joined Bayer AG in Leverkusen as a Commercial Trainee on April 1, 1966. Mr. Baumann served as a Member of Management Board at Bayer ...

Read Full Background

Corporate Headquarters*

Kaiser-Wilhelm-Allee 1
Leverkusen, North Rhine-Westphalia 51368

Germany

Phone: 49 214 301
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Universität zu Köln
Unknown/Other Education
Rheinisch-Westfälische Technische Hochschule Aachen

Other Affiliations*

Annual Compensation*

Salary€888,000
Bonus€881,000
Total Annual Compensation€1,769,000

Stock Options*

Restricted Stock Awards€1,133,000
All Other Compensation€232,000

Total Compensation*

Total Annual Cash Compensation€2,001,000
Total Short Term Compensation€1,769,000
Other Long Term Compensation€1,365,000
Total Calculated Compensation€3,134,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYN:GR €110.71 EUR +1.55

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Andrew N. Liveris Executive Chairman, Chief Executive Officer and President
The Dow Chemical Company
$1.9M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.